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Summary: The simultaneous determination of the catalytic activities in serum of monoamine oxidase (EC
1.4.3.4) and N-acetyl-ß-D-glucosaminidase (EC 3.2.1.30) was performed in patients with various non-liver
diseases, acute hepatitis and fibroproliferative liver disorders (cirrhosis and fibrosis) and the predictive values
of the positive (both activities are pathologically elevated) and negative test results (normal activity of monoa-
mine oxidase and/or N-acetyl-ß-Z)-glucosaminidase) were estimated. It was found that the incidence of the
positive result is extremely low (0.024, 5/207) in patients suffering from a gfeat variety of non-liver and liver
diseases (except cirrhosis) but rather great in liver cirrhotic subjects (0.44, 18/41). A fraction of only 0.07 of
liver fibrotic patients had a positive test result. Based on these data the estimated predictive value of the
positive result for liver cirrhosis at a prevalence of 0.03 is 0.47. This value increases strorigly with higher
prevalence of cirrhosis (population preselected for ehronic liver diseases). The negative predictive value for
cirrhosis and the positive value for fibrosis are löw. Thüs, the probability of the presence of cirrhosis in
patients with suspected ehronic liver diseases is great in cases of abnormally high activities of both monoamine
oxidase and N-äcetyKß-D-glucosaminidase. Negative test results (normal catalytic activities of one or both
enzymes), hpwever, do not prove the absence of liver cirrhosis and/or liver fibrosis.
Die diagnostische Leistungsfähigkeit der kombinierten Bestimmung der Monoaminoxidase und N-Acetyl-ß-D-
Glucosaminidase im Serum für fibroproliferative Lebererkrankungen
Zusammenfassung: Die gleichzeitige Bestimmung der katalytischen Aktivitäten im Serum von Monoaminoxi-
dase (EC 1.4.3.4) und N-Acetyl-ß-D-Glucosaminidase (EC 3.2.1.30) wurde bei Patienten mit verschiedenen
Nicht-Lebererkrankungen, akuter Hepatitis und fibroproliferativen Lebererkrankungen (Lebercirrhose und
-fibröse) durchgeführt und die Vorhersagewerte des positiven (beide Enzymaktivitäten pathologisch erhöht)
und negativen Testergebnisses (normale Aktivität der Monoaminoxidase und/oder N-Acetyl-ß-D-GIucos-
aminidase) wurden geschätzt. Die Ergebnisse zeigen, daß die Häufigkeit des positiven Ergebnisses extrem
niedrig (0,024, 5/207) ist bei Patienten mit sehr verschiedenen Nicht-Leber- und Lebererkrankungen (aus-
genommen Lebercirrhose), aber groß ist bei lebercirrhotischen Patienten (0,44, 18/41). Ein Anteil von nur
0,07 der leberfibrotischen Patienten hat ein positives Testergebnis. Basierend auf diesen Werten beträgt der
geschätzte Vorhersagewert des positiven Ergebnisses 0,47 für Lebercirrhosen, wenn deren Prävalenz mit 0,03
angenommen wird. Dieser Wert nimmt mit größerer Prävalenz der Lebercirrhose (für chronische Leberer-
krankungen präselektionierte Population) stark zu. Der negative Vorhersagewert für Cirrhose und der posi-
tive Wert für Fibrösen sind niedrig. Somit ist die Wahrscheinlichkeit des Vorliegens einer Lebercirrhose bei
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Patienten mit vermuteten chronischen Lebererkrankungen im Falle pathologisch erhöhter Monoaminoxidase
und N-Acetyl-ß-D-Glucosaminidase-Aktivitäten hoch. Negative Testergebnisse (normale katalytische Ak-
tivität eines der oder beider Enzyme) schließen jedoch eine Lebercirrhose und/öder Leberfibrose nicht aus.
Introduction
Although there has been a substantial increase in re-
cent years in our knowledge of the metabolism and
structure of various connective tissue components,
such äs collagen (l -3), proteoglycans (4), and struc-
tural glycoproteins (2-5) in normal and fibrotic liv-
er, the pathobiochemical mechanisms of intercellülar
excess deposition and molecular decomposition in
chronically injured liver parenchyma are still not
fully understood (3, 6, 7). The largely unknown pa-
thogenesis of the fibrotic transition of the diseased
liver, the chronicity of the fibrotic process and the
ubiquitous distribütion of the connective tissue com-
ponents in the body might be the main reason why,
despite intense efforts, the search for clinically relia-
ble, organ- and disease-specific and sensitive bioche-
mical parameters of fibrotic liver diseases (fibrosis
and cirrhosis, respectively) has so far been rather un-
successful. Among several parameters of collagen
and proteoglycan/glycoprotein metabolism (4, 8, 9)
the determinations of the activities in serum of mo-
noamine oxidase (EC 1.4.3.4) (10-13) and N-ace-
tyl-ß-D-glucosaminidase (EC 3.2.1.30) (14-19)
have been proposed äs potential useful diagnostic
tools. During the evaluation of their diagnostic valid-
ity (20, 21) it was found that the combined determi-
nation of both enzymes can be of help in substantiat-
ing liver cirrhosis.
Materials and Methods
Specimen collection
The activities of monoamine oxidase and N-acetyl-ß-D-glucos-
aminidase were measured in sera of 114 patients with a great
variety of non-liver diseases (including malignant and benign tum-
ours, diseases of the gastro-intestinal tract and cardio-vascular
System, diabetes mellitus, dermatological and neurological dis-
orders and various, unspecified forms of non-liver diseases), in
sera of 51 patients with non-fibrotic liver diseases (including
cholecystitis, acute viral hepatitis, chronic active hepatitis, chronic
persistent hepatitis) and 83 patients with fibrotic (fibrosis, cirrho-
sis) liver diseases. The subdivision of chronic and acute liver dis^
eases is based on the results of clinical investigation, liver function
tests and histologic examination of liver biopsy specimens, respec-
tively, äs reported elsewhere (20).
Determination of monoamine oxidase activity (EC 1.4.3.4) in se-
rum
Enzyme catalytic activity was measured in serum either instantly
after venous blood collection or, if not possible, in sera which
were deep-frozen for 5 to 8 days to avoid loss of catalytic activity
(22). The colorimetric procedure of Ono et al. (23) including
modifications äs described was applied (22). The änalytical reliä-
bility of the test has been reported (22).
Determination of N-acetyl-ß-D-glucosaminidase activity (EC
3.2.1.30) in serum
In principal, the procedure of Findlay et al. (24) using p-nitro-
phenyl-ß-D-glucosaminide äs Substrate was followed. Some mod-
ifications incorporated into the test and analytjcal criteria have
been described recently (21).
Statistical analyses
Estimates of the diagnostic criteria of the combined use of monoa-
mine oxidase and N-acetyl-ß-D-glucosaminidase, i.e. diagnostic
sensitivity, specificity, positive and negative predictive vaiues, are
based on definitions (25) summarized in more detail previously
(20, 21). A positive test result is defined äs pathologically elevat-
ed catalytic concentrations of both monoamine oxidase (> 630 U/
1) and N-acetyl-ß-D-glucosaminidäse (> 32 U/l). A negative re-
sult is givefi if the catalytic concentrations of monoamine oxidase
(^ 630 U/l) and/ör N-acetyl-ß-D-glucosamiiiidase (^ 32 U/l) do
not exceed the upper limit (+2s) of the reference ränge.
Results
Correlation ofthe catalytic concentrations of monoa-
mine oxidase and N-acetyl-ß-D-glucösärriinidase in
sera of patients with fibrotic liver diseases and non-
liver disördefs
The majority of patients (89/144) suffering frorn
non-liver and nonfibrotic liver diseases had both
normal monpämme oxidase (^630 U/l)
 fcandl .N-äce-
tyl-ß-D-glucosaminidase (^32 U/1) (fig. la). Patho-
logically elevated catalytic concentrations of N-ace-
tyl-ß-D-glucosaminidase (46/144) were far more
frequent thail abnormaliy high cataiytic concentra^
tions of monoamine oxidäse (11/144). it is note-
worthy that the fraction of patients häVing both ele-
vated catalytic concentrations of monoamine oxidase
and N-acetyl-ß-D-glucosaminidäse was found to be
very small (0.014, 2/144). In all cases of patients af-
flicted with acute viral hepatitis catalytic concentra-
tions of monoamine oxidase were within the normal
ränge, but elevated catalytic concentrations of N-
äcetyl-ß-D-glucosaminidase were noted in a fraction
of 0.71 (15/21) (fig. Ib). Thus, in contrast to the lät-
ter enzyme, catalytic concentrations of monoamine
oxidäse in serum obviously are not influenced by the
process of liver cell necrosis.
In the group of liver fibrosis the pfoportion of pa-
tients having pathologically increased catalytic con-
centrations of N-acetyl-ß-D-glucosaminidase (0.50,
21/42) was found to be quite largef thän that with
abnormal catalytic concentrations of monoamine ox-
idase (0.17,7/42) (fig. Ic). Even anxqng liver fibrotic
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subjects the incidence of abnormally elevated cata-
lytic concentrations of both enzymes was very low
(0.07, 3/42). In contrast to the patients with non-liv-
er diseases, ηοη-fibrotic liver disorders and liver fi-
brosis, a quite large fraction (0.44,18/41) of subjects
suffering from liver cirrhosis had both pathologically
elevated catalytic concentrations of monoamine oxi-
dase and N-acetyl- -D-glucosaminidase (fig. Id).
Abnormally high catalytic concentrations of monoa-
mine oxidase (0.56, 23/41) occured less frequently
than elevated catalytic concentrations of N-acetyl- -
D-glucosaminidase (0.71, 29/41). Normal catalytic
concentrations of both enzymes were found in only
7/41 patients with liver cirrhosis. Compared with da-
ta shown in figure Ic the transition of liver fibrosis to
cirrhosis is accompanied by a considerable increase
in the fraction of patients having both abnormal ca-
talytic concentrations of monoamine oxidase and N-
acetyl- -D-glucosaminidase, which is mainly due to
an increase in the proportion of pathologically ele-
vated catalytic concentrations of monoamine oxidase
among liver cirrhotic subjects. In patients suffering
from a great variety of non-liver and liver diseases
, (except liver cirrhosis) the fraction with pathologi-
cally elevated catalytic concentrations of both en-
zymes is very small (0.024, 5/207), but this fraction
is nearly 20 times greater (0.44) in the population of
cirrhotics.
14001
1200
1000
800
600
_ 400
i
7 200
σ;p
"x0
 0
o>
| 1500
1 1400
1200
1000
800
600
400
200
0
α
-
-·
•
«W · 4>
— · ··*«·!
•/*><§Γ585>
_ Ι/φΈφ
Γ ·" ι
'.
φ :.
"-% ' .
··· * ·$·
•4M · ·
• · ·
• ι ι ι ι ι _
15 30 45 60 75 90 105
c
-
-
-
- ..
• ·
** ir
" Λ
1 J
:
• ·
1 1 1 1 1 __
15 30 45 60 75 90 105
1400
1200
1000
800
600
400
200
0
1600
1400
1200
1000
800
600
400
200
b
-
-
-
- '
-
• · ··
l l 1 1 1 -
15 30 45 60 75 90 105
" d
-
-
-
" ·
 :
• \
i j
•
• ·
• ·
• ·· ·
1 1 1 1 1 _
0 15 30
N-Acety l - - Glueosomimdose [U/l]
45 60 75 90 105
Fig. 1. Correlation pf the catalytic concentrations of monoamine oxidase and N-acetyl- -D-glucosaminidase in sera of patients with
miscellaneous non-liver and non-fibrotic liver diseases (a, n = 144, r = 0.022), acute viral hepatitis (b, n = 21, r = 0.519), liver
fibrosis (c, n = 42, r = -0.031), and liver cirrhosis (d, n = 41, r = 0.048).
Nurjibered circles in a indicate the cases with identical catalytic concentrations of both enzymes. The diagrams are subdivided by
lines marking the upper "normal" mit (+2s value) of catalytic concentrations of both enzyme activities.
Predictive values of the combined determination of
monoamine oxidase and N-acetyl-$-D-glucosamini-
dose for liver fibrosis and cirrhosis
The results described above suggest that the simul-
taneous determination of monoamine oxidase and
N-acetyl- -D-glucosaminidase might provide an aid
in the diagnosis of liver cirrhosis. Therefore predic-
tive values of the positive (pathologically elevated
activities of both enzymes) and negative test result
(normal activities of one or both enzymes) were esti-
mated with respect to a reference population includ-
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ing non-liver and liver diseases (except fibrosis and
cirrhosis). As anticipated from the data in figure Id
and documented in figures 2 and 3, predictive values
of the positive result are much better than those of
the negative test result. Based on a prevalence of
chronic liver diseases (including cirrhosis and fibro-
sis) of 0.03 in West-Germany (26), the positive pre-
dictive value is estimated to be 0.34 (sensitivity 0.20,
specificity 0.988) for fibrosis and cirrhosis (fig. 2).
For liver cirrhosis alone (fig. 3) the respective pre-
dictive values is 0.47 (sensitivity 0.341, specificity
0.988). Clearly, the predictive values improve
0.1
0.1 0.5 ' 1.0
Prevalence of cirrhosis and fibrosis
Fig. 2. Predictive values of the positive (both monoamine oxidase
and N-acetyl-ß-D-glucosaminidase are pathologically ele-
vated) and negative test result (one or both enzymes are
within the reference ränge) äs a function of disease prevaK
ence (liver cirrhosis and fibrosis). The reference popula-
tion consists of patients with various non-liver and non-fi-
brotic liver diseases including cases with acute hepatitis.
indicates predictive values of a hypothetical test,
in which the decision between positive and negative result
is made by coin tossing (further explanation in results).
Prevalence of cirrhosis
Fig. 3. Predictive values of the positive and negative test result,
defined äs in fig. 2, äs a function of disease prevalence
(liver cirrhosis). Reference population and definition of a
hypothetical test (~——) are described in fig. 2.
strongly among patients selected for chronic liver
disorders (figs. 2, 3). Thus, at a prevalence of cirrho-
sis of only 0.20 the probability of the presence of
liver cirrhosis in the case of a positive test result is
greater than 0.85 (fig. 3).
In relation to the positive predictive Values of a hy-
pothetical test, in which the decision between posi-
tive and negative resült is made by coin tossing (the
worst of all tests which do not give systematically
wrong results, dotted lines in figs. 2 and 3), the maxi-
mal gain of Information obtainable by the determi-
nation of the cätalytic concentration of monoamine
oxidase and N-acetyl-ß-Z)-glueosaminidase, i.e.
maximum difference between the curve and dotted
line in direction of the y-axis (fig. 3), is about 67 per
cent pöiiits for liver cirrhosis.
Disciission
The data provided in this study clearly docüment
that, in comparison with N-acetyl-ß^D-glucosamini-
dase, monoamine oxidase has a greater diagnostic
specificity for liver cirrhösis. However, the former
enzyme proves to have a better diagnostic sensitivity
than the latter. The simültaneous determination of
both enzymes in patients with suspected chronic liver
diseases is suggested äs a diagnostic aid for substan-
tiating the presence of liver cirrho$is. The predictive
value for this disease reached by the positive test re-
sult (0.47 at a prevalence of disease öf 0.03) is higher
than thät pbtained by the single determination of
monoamine oxidase (0.30) (20) and far greater than
that of N-äcetyl-ß-D-glucosaminidase (0.07) (21).
Since the predictive values increase strongly with
higher prevalence of cirrhotic subjects (fig. 3) the va^
lidity of a positive test result for cirrhosis becomes
quite great in a population selected for hepatological
disorders. However, the fact that the predictive
values of negative test results are low should not be
ignored, i.e. normal cätalytic concentrations of mo-
noamine oxidase and/or N-acetyl-ß-D-glucösämini-
dase do not prove the absence of liver cirrhosis. Fur-
therrnore, the combined determination of both en*
zymes does not help in the diagnosis of liver fibrosis,
due chiefly to the low incidence of pathologically
elevated monoamine oxidase in this category of dis-
eases. In conclusion, the probability of the presence
of liver cirrhosis is high if the cätalytic concentrations
of both monoamine oxidase and N-acetyl-ß-D-glu*
cosaminidase are pathologically elevated in patients
with suspected chronic liver diseases (population
preselected for cirrhosis). The combined determina-
tion of both enzymes is of no use for the early detec-
tion of fibroproliferative liver disepses.
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